Free Trial

Extendicare (EXE) Competitors

Extendicare logo
C$13.70 -0.07 (-0.51%)
As of 07/4/2025 04:00 PM Eastern

EXE vs. DNTL, SIA, WELL, DR, KDA, NLH, PHA, BLU, TRIL, and BHC

Should you be buying Extendicare stock or one of its competitors? The main competitors of Extendicare include dentalcorp (DNTL), Sienna Senior Living (SIA), WELL Health Technologies (WELL), Medical Facilities (DR), KDA Group (KDA), Nova Leap Health (NLH), Premier Health of America (PHA), BELLUS Health (BLU), Trillium Therapeutics (TRIL), and Bausch Health Companies (BHC). These companies are all part of the "medical" sector.

Extendicare vs. Its Competitors

Extendicare (TSE:EXE) and dentalcorp (TSE:DNTL) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their analyst recommendations, institutional ownership, earnings, dividends, media sentiment, risk, valuation and profitability.

19.2% of Extendicare shares are owned by institutional investors. Comparatively, 50.3% of dentalcorp shares are owned by institutional investors. 13.9% of Extendicare shares are owned by company insiders. Comparatively, 0.2% of dentalcorp shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Extendicare has higher earnings, but lower revenue than dentalcorp. dentalcorp is trading at a lower price-to-earnings ratio than Extendicare, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
ExtendicareC$1.46B0.78C$65.46MC$0.7817.47
dentalcorpC$1.49B1.05-C$80.68M-C$0.43-19.36

In the previous week, dentalcorp had 1 more articles in the media than Extendicare. MarketBeat recorded 1 mentions for dentalcorp and 0 mentions for Extendicare. Extendicare's average media sentiment score of 0.32 beat dentalcorp's score of -2.00 indicating that Extendicare is being referred to more favorably in the media.

Company Overall Sentiment
Extendicare Neutral
dentalcorp Very Negative

Extendicare has a beta of 1.26, suggesting that its share price is 26% more volatile than the S&P 500. Comparatively, dentalcorp has a beta of 1.26, suggesting that its share price is 26% more volatile than the S&P 500.

Extendicare has a net margin of 4.48% compared to dentalcorp's net margin of -5.40%. Extendicare's return on equity of 64.13% beat dentalcorp's return on equity.

Company Net Margins Return on Equity Return on Assets
Extendicare4.48% 64.13% 7.16%
dentalcorp -5.40%-4.71%0.77%

Extendicare currently has a consensus target price of C$13.50, suggesting a potential downside of 1.46%. dentalcorp has a consensus target price of C$12.59, suggesting a potential upside of 51.19%. Given dentalcorp's stronger consensus rating and higher probable upside, analysts plainly believe dentalcorp is more favorable than Extendicare.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Extendicare
0 Sell rating(s)
3 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00
dentalcorp
0 Sell rating(s)
0 Hold rating(s)
6 Buy rating(s)
0 Strong Buy rating(s)
3.00

Summary

Extendicare beats dentalcorp on 8 of the 15 factors compared between the two stocks.

Get Extendicare News Delivered to You Automatically

Sign up to receive the latest news and ratings for EXE and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding EXE and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

EXE vs. The Competition

MetricExtendicareMedical Care Facilities IndustryMedical SectorTSE Exchange
Market CapC$1.14BC$1.58BC$5.53BC$6.19B
Dividend Yield4.42%4.04%5.24%6.72%
P/E Ratio17.477.1027.6450.85
Price / Sales0.7814.24416.591,194.54
Price / Cash3.2012.3236.8983.29
Price / Book9.822.078.034.69
Net IncomeC$65.46MC$58.06MC$3.18BC$301.20M
7 Day Performance-1.08%2.86%2.92%2.28%
1 Month Performance-5.06%4.92%3.72%4.71%
1 Year Performance90.28%54.04%35.14%26.90%

Extendicare Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
EXE
Extendicare
0.8482 of 5 stars
C$13.70
-0.5%
C$13.50
-1.5%
+90.3%C$1.14BC$1.46B17.4723,000Dividend Announcement
DNTL
dentalcorp
1.5659 of 5 stars
C$8.42
+2.8%
C$12.59
+49.6%
+2.8%C$1.58BC$1.49B-19.579,950Negative News
Dividend Cut
SIA
Sienna Senior Living
0.593 of 5 stars
C$19.05
+1.4%
C$18.79
-1.4%
+29.4%C$1.58BC$938.65M47.1612,000Dividend Announcement
WELL
WELL Health Technologies
3.1397 of 5 stars
C$4.06
+2.0%
C$8.08
+98.9%
-12.2%C$1.01BC$962.00M13.76510News Coverage
DR
Medical Facilities
0.7132 of 5 stars
C$15.80
+1.9%
C$14.75
-6.6%
+28.8%C$257.06MC$388.07M10.581,833
KDA
KDA Group
N/AC$0.29
flat
N/A+33.3%C$49.99MC$28.71M-7.503,100News Coverage
NLH
Nova Leap Health
N/AC$0.27
+1.9%
N/A+0.0%C$15.35MC$16.71M-33.28N/A
PHA
Premier Health of America
N/AC$0.05
-9.1%
N/A-84.7%C$2.78MC$158.32M-0.22N/AGap Down
BLU
BELLUS Health
N/AN/AN/AN/AC$2.47BC$16K-20.2974
TRIL
Trillium Therapeutics
N/AN/AN/AN/AC$2.45BC$43K-34.0633
BHC
Bausch Health Companies
N/AC$9.08
+2.8%
N/A-1.3%C$2.36BC$6.69B-13.2919,900Positive News

Related Companies and Tools


This page (TSE:EXE) was last updated on 7/5/2025 by MarketBeat.com Staff
From Our Partners